A review suggests that exercise may reduce symptoms of depression, offering an additional avenue for the treatment of ...

For late adolescents and young adults, weekend catch-up sleep may reduce the incidence of daily depressive symptoms.

Among geriatric surgery patients, psychological distress is common and may be associated with postoperative outcomes.

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list includes several groundbreaking therapies that are expected to change the ...

Breastfeeding seems to be associated with a lower risk for depression and anxiety in women of later reproductive age.

The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.

Email communications may be an effective strategy for improving clinician engagement with prescription drug monitoring ...

A personalized 3-month resistance exercise program improved walking distance and HRQOL in adults with persistent COVID-19 symptoms.

With medication for opioid use disorder, the benefit of retention on patient survival persists through about 4 to 5 years of treatment.

Women endurance athletes experience a high frequency of menopausal symptoms, some of which are perceived to negatively impact performance.

Service-bridging mechanism reduces referral wait times and improves symptoms in older adults with mild to moderate depression.

Adverse prenatal exposures are associated with altered developmental trajectories, impacting psychopathology and maturation into adolescence.